Literature DB >> 33972738

IL-33 in COVID-19: friend or foe?

Yuejin Liang1,2, Yiyue Ge3, Jiaren Sun4,5.   

Abstract

Entities:  

Year:  2021        PMID： 33972738     DOI： 10.1038/s41423-021-00685-w

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  1 in total

1.  Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia.

Authors:  Qin Liu; Huai Chen; Qingsi Zeng
Journal:  J Infect       Date:  2020-07-11       Impact factor: 6.072
  1 in total
  15 in total

1.  The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.

Authors:  Shima Makaremi; Ali Asgarzadeh; Hamed Kianfar; Alireza Mohammadnia; Vahid Asghariazar; Elham Safarzadeh
Journal:  Inflamm Res       Date:  2022-06-25       Impact factor: 6.986

Review 2.  The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Authors:  Ren-Jun Hsu; Wei-Chieh Yu; Guan-Ru Peng; Chih-Hung Ye; SuiYun Hu; Patrick Chun Theng Chong; Kah Yi Yap; Jamie Yu Chieh Lee; Wei-Chen Lin; Shu-Han Yu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 3.  Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review.

Authors:  Sagnik Sen; Naresh Babu Kannan; Jayant Kumar; Renu P Rajan; Karthik Kumar; Girish Baliga; Harshavardhan Reddy; Anubhav Upadhyay; Kim Ramasamy
Journal:  Int Ophthalmol       Date:  2021-08-11       Impact factor: 2.031

4.  IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding.

Authors:  Sofija Sekulic Markovic; Marina Jovanovic; Nevena Gajovic; Milena Jurisevic; Nebojsa Arsenijevic; Marina Jovanovic; Milan Jovanovic; Zeljko Mijailovic; Snezana Lukic; Nenad Zornic; Vladimir Vukicevic; Jasmina Stojanovic; Veljko Maric; Miodrag Jocic; Ivan Jovanovic
Journal:  Front Med (Lausanne)       Date:  2021-11-30

Review 5.  The Role of Epithelial Damage in the Pulmonary Immune Response.

Authors:  Rachel Ann Burgoyne; Andrew John Fisher; Lee Anthony Borthwick
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

Review 6.  COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines.

Authors:  Shagnik Chattopadhyay; Sayantee Hazra; Arman Kunwar Hansda; Biswajit Biswas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2022-03-15       Impact factor: 6.986

7.  Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.

Authors:  Jennifer Sasson; Alexandra N Donlan; Jennie Z Ma; Heather M Haughey; Rachael Coleman; Uma Nayak; Amy J Mathers; Sylvain Laverdure; Robin Dewar; Patrick E H Jackson; Scott K Heysell; Jeffrey M Sturek; William A Petri
Journal:  medRxiv       Date:  2022-05-19

8.  The difference of the inflammatory milieu in MIS-C and severe COVID-19.

Authors:  Sibel Lacinel Gurlevik; Yasemin Ozsurekci; Erdal Sağ; P Derin Oygar; Selman Kesici; Ümmüşen Kaya Akca; Muserref Kasap Cuceoglu; Ozge Basaran; Sultan Göncü; Jale Karakaya; Ali Bülent Cengiz; Seza Özen
Journal:  Pediatr Res       Date:  2022-03-29       Impact factor: 3.756

Review 9.  CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 10.  Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy.

Authors:  Giuseppe Murdaca; Francesca Paladin; Alessandro Tonacci; Matteo Borro; Monica Greco; Alessandra Gerosa; Stefania Isola; Alessandro Allegra; Sebastiano Gangemi
Journal:  Biomedicines       Date:  2022-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.